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Abstract
The number of children in the US taking prescription drugs for emotional and behavioral
disturbances is growing dramatically. This growth in the use of psychotropic drugs in pediatric
populations has given rise to multiple controversies, ranging from concerns over off-label use and
long-term safety to debates about the societal value and cultural meaning of pharmacological
treatment of childhood behavioral and emotional disorders. This commentary summarizes the
authors' eight main findings from the first of five workshops that seek to understand and produce
descriptions of these controversies. The workshop series is convened by The Hastings Center, a
bioethics research institute located in Garrison, New York, U.S.A.
Introduction
According to Rutter et al., during the industrialized
world's postwar period, "as physical health was improv-
ing, psychosocial disorders were becoming more frequent
[1]." The cause or causes of this increase are debated. In
2000, the US Surgeon General estimated that approxi-
mately one in five children and adolescents experience the
signs and symptoms of a recognized (DSM-IV) disorder
during the course of a year, of whom about 5% experience
"extreme functional impairment" [2]. Some more recent
studies support this finding, arguing that a majority of dis-
orders begin before 14 years of age [3], with a significant
portion already manifest in preschoolers [4].
In parallel developments, the number of children in the
US taking prescription drugs for these disorders is growing
dramatically [5,6]. Recent trends in psychotropic medica-
tion use from large population-based studies show sub-
stantial growth in pediatric and adolescent use of
antidepressants [7] and stimulants [8]. According to a
study by Medco Health Solutions, an organization that
monitors drug spending, the numbers of children under
19 years of age who are taking one or more behavioral
drugs rose over 20% between 2000 and 2003, with spend-
ing on medications to treat attention deficit disorder ris-
ing 183%, antidepressants rising 27%, and medications to
treat autism and conduct disorders rising more than 60%
in that period [9]. Other studies support these findings
regarding the upward trend in the use of psychotropic
medications in children [10,11]. This trend has given rise
to multiple controversies, ranging from concerns over off-
label use and long-term safety to debates about the soci-
etal value and cultural meaning of pharmacological treat-
ment of childhood behavioral and emotional
disturbances [12-16]. While different positions on these
controversies are often expressed in the specialist and lay
literatures [12,17,18], few attempts have been made to
engage with the controversies in order to learn both what
they can tell us about the facts and values at issue, as well
as whether there are in fact areas of agreement.
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Method
In response to these controversies, The Hastings Center, a
bioethics research institute in Garrison, New York applied
for and was awarded a Cooperative Agreement Confer-
ence grant from the U.S. National Institute of Mental
Health. The grant allows the Principal Investigator, Erik
Parens, and Co-Principal Investigator, Josephine Johnston
to conduct a 3-year project built around five workshops.
The 2-day workshops give a highly diverse and distin-
guished group of approximately 22 practitioners and
scholars an opportunity to talk carefully and respectfully
over time. Unlike typical conference presentations, work-
shop presentations are commissioned to build on one
another and each session of three presentations is fol-
lowed by, on average, sixty minutes of sustained debate by
participants seated around one table. Two facts about
these workshops – that they are interdisciplinary and that
they entail face-to-face interaction over time [19] – make
them especially well suited to analyzing complex issues
and producing new insights.
Studies of interdisciplinary interaction and distributed
research groups support this method [20]. Julie Klein and
other leading authorities on interdisciplinary projects and
processes have written about the epistemic power that a
multi-perspective approach brings to the production, cri-
tique, and dissemination of knowledge [21-24]. Studies of
"distributed" research groups show that the success of col-
laborative research undertaken by geographically dis-
tanced teams depends on regular face-to-face meetings
[26] in environments that encourage researchers to treat
each other as equals [27]. The NIH Roadmap also sup-
ports interdisciplinary research, noting that: "By engaging
seemingly unrelated disciplines, traditional gaps in termi-
nology, approach, and methodology might be gradually
eliminated. With roadblocks to potential collaboration
removed, a true meeting of minds can take place: one that
broadens the scope of investigation into biomedical prob-
lems, yields fresh and possibly unexpected insights, and
may even give birth to new hybrid disciplines that are
more analytically sophisticated [25]." The Roadmap's
description applies equally well to the combination of sci-
entific and humanistic disciplines in this workshop series.
The first workshop, held in March 2007 in New York City
and reported on in this commentary, aimed to produce an
overview of most of the major controversies. Each of the
next three workshops is focused around a single child-
hood emotional or behavioral disturbance and considers
the major controversies as well as some that are specific to
the particular disorder: the second workshop, held in
October 2007, was built around a discussion of ADHD;
the third and fourth workshops will be built around dis-
cussions of pediatric bipolar disorder and depression,
respectively. The final workshop will synthesize the first
four and will identify emerging issues for further study.
The project's Steering Committee, consisting of the PI and
Co-PI together with Benedetto Vitiello (NIMH), Sara
Harkness (University of Connecticut), and Steven Hyman
(Harvard University), is primarily responsible for leading
the project, including selecting workshop participants.
Workshop participants are selected based on their accom-
plishments of direct relevance to the controversies, their
willingness to apply themselves afresh to the workshops'
on-going conversation, and their willingness to contribute
toward one or more products. Some participants will
attend all or nearly all of the workshops, while others will
attend only one or two workshops depending on their
expertise and availability.
The Steering Committee invited participants from many
disciplines (including child psychiatry, neurobiology, epi-
demiology, philosophy, anthropology, and sociology) as
well as researchers who emphasize different positions.
The first workshop included those who aim to understand
childhood emotional and behavioral disturbances in bio-
logical terms and those who begin their inquiries at the
level of environment and culture. Because researchers
emphasize different insights, we invited clinicians who
emphasize the effectiveness of psychotropic medications
in childhood, those who are concerned about prescription
levels, and those who study the effectiveness of non-phar-
macological treatments. We also invited researchers who
have been part of DSM- and ICD-related efforts to articu-
late reliable and valid diagnoses and individuals who
have written critically about diagnostic categories, as well
as researchers who could speak directly to the roles of
nature and nurture in the emergence of childhood distur-
bances, the problems of over and under-treatment, as well
as the problem of stigma and the problem of the desire for
diagnostic labels.
Ultimately, the project aims to produce a fair description
of the interconnected controversies and areas of agree-
ment related to the use of drugs in treating childhood
behavioral and emotional disturbances and to identify
areas where further conversation and research are
required. The project does not seek consensus. Although
one or more of these controversies has been addressed by
individuals or specialist groups, we have not found publi-
cations or other reports by groups including such a wide
variety of disciplines and perspectives. We therefore
believe that our findings will shed new light on the precise
nature of the controversies over the pharmacological
treatment of emotional and behavioral disturbances in
children, including the areas of agreement and disagree-
ment. For example, it may be that deep disagreement
exists over whether it makes a moral difference whetherChild and Adolescent Psychiatry and Mental Health 2008, 2:5 http://www.capmh.com/content/2/1/5
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one uses pharmacological or non-pharmacological treat-
ments in children, yet it may be that there is nonetheless
widespread agreement that more money and effort should
be directed towards establishing stable home and school
environments for children. Our findings will then be
communicated to various audiences in oral presentation,
articles (such as this commentary), a book of essays, a
report, and a web-based e-briefing.
Findings: Agreement and divergence at 
workshop 1
The commentary you are now reading summarizes the
findings from the first of the five workshops. Although all
workshop participants (see acknowledgements) have had
an opportunity to suggest or request changes to the com-
mentary, it is the sole work of the authors and reflects our
understanding of the controversies discussed at the work-
shop. The commentary identifies 8 major points about
which we and the workshop participants (WP) agreed and
that we think require recognition within the specialist and
lay communities. After identifying a major point of agree-
ment, we then identify areas of disagreement – or, more
accurately, areas of differing emphasis. Unless otherwise
specified, quotation marks indicate that the words were
spoken by participants at the workshop or appeared in
their Power Point presentations or handouts.
1. Human societies have an obligation to help children 
(and families) who are suffering from behavioral or 
emotional disturbances
Different WPs did, however, emphasize different ways in
which we should work to relieve suffering from emotional
and behavioral disturbances. Some WPs tended to focus
on what might be done to help the individual child now.
For example, Carol Caruso, who works on behalf of the
National Alliance on Mental Illness, focuses on finding
ways to help parents to quickly and efficiently ameliorate
their child's suffering. She rarely has time to ask about the
distal causes of that child's emotional or behavioral dis-
turbance or to speculate about the potential wider cultural
or social effects of whatever treatment is chosen.
Other WPs, however, like anthropologist Sara Harkness
and developmental psychologist Charles Super, focus on
"the relationship between the developing child and the
environment [i.e., the culture]" that contributes to pro-
ducing emotional and behavioral disturbances in chil-
dren. Harkness and Super referenced studies they have led
that examine the cultural belief systems and daily lives of
children and parents – with a view to getting a clearer pic-
ture of the relationship between different parenting styles
and different rates of childhood psychiatric diagnoses.
Though social scientists seek to make descriptive rather
than evaluative claims, one reading of the Harkness-Super
data is that it supports two related but different evaluative
claims about how American culture can produce suffering
in children [28]. First, their comparison of American and
Dutch parenting styles suggests that Americans are more
prone than the Dutch to create environments that over-
stimulate children [29] and thus inadvertently create the
behaviors that drugs like Ritalin are intended to treat. Sec-
ond, their comparison of American and Italian parenting
styles suggests that Italian parents are less likely to con-
sider the mood of their children to be problematic [30],
making them less prone to label their children as develop-
mentally abnormal and thus less likely to inadvertently
create the suffering that sometimes attends getting a psy-
chiatric diagnosis or taking medication.
2. To understand the emergence of childhood emotional 
and behavioral disturbances, we need an "ecological" or 
"systems" or "interactionist" approach – an approach that 
studies biological and environmental variables as they 
interact over time
Some WPs emphasized the role of biological variables.
When these WPs think of depression, for example, they
think first of the important role of genetic  differences,
which has been demonstrated by traditional (twin, adop-
tion, and family) behavioral genetics studies – and they
also think of recent findings from molecular genetics and
neuroanatomy, which describe correlations between
genetic or anatomical and functional differences and dif-
ferences in mood and behavior [31-33].
Other WPs, however, tended to emphasize the role of
environmental variables. For example, pharmacological
epidemiologist Julie Zito cited psychiatrist Leon Eisen-
berg, who said: "All children inherit – along with their
parents' genes – their parents, their peers, and the commu-
nities they live in" [34]. When these WPs think of depres-
sion, they think first of research on the role of
environmental differences and neuroscience research that
shows the role of stress [35]. Psychologist-behavioral
geneticist, Julia Kim-Cohen, presented emerging research
on gene-environment interactions that aims to help us
better understand why, when children are exposed to
environmental risks, some go on to develop mental disor-
ders while others do not. This evidence suggests that genes
can moderate the impact of environmental "pathogens,"
such as physical maltreatment, on the risk for developing
mental disorders [36-38].
3. DSM IV's – and ICD 10's – categorical approach to 
mental disorders does not represent clinical reality as 
accurately as would a dimensional approach
At least three WPs (psychiatrists Michael First, Steven
Hyman, and Benedetto Vitiello) said that "the reification"
of DSM categories is a significant problem. Psychiatrist
John Sadler pointed out that the Introduction to DSM IVChild and Adolescent Psychiatry and Mental Health 2008, 2:5 http://www.capmh.com/content/2/1/5
Page 4 of 9
(page number not for citation purposes)
actually grants that a dimensional approach would better
reflect clinical reality than the categorical one does – that it
is usually a serious mistake to speak as if bright lines sep-
arate the categories of health and disease or separate cate-
gories of disease. Indeed, Michael First, one of DSM IV's
editors, said in no uncertain terms that " [there are] no
'zones of rarity' between normal and disorder or between
disorders (e.g., schizophrenia – schizoaffective disorder –
psychotic mood disorder)." Alas, as Sadler noted, "The
introduction to DSM IV is really excellent. The problem is
nobody reads it."
Michael First proposed that "Most comorbidity is an arti-
fact of the [DSM] system" and that "as categories are more
narrowly defined, more [disorders] are present in the
same patient [and thus patients receive more treat-
ments]." Indeed, Benedetto Vitiello showed a slide indi-
cating the extraordinary overlap among the diagnoses
ADHD, Tic Disorder, Mood Disorder, Conduct Disorder,
and Oppositional Defiant Disorder. He suggested that we
do not know whether these comorbidities point toward
one underlying psychopathology or many.
Vitiello also pointed out the more general problem that,
while DSM diagnoses are reliable across trained raters, the
current DSM approach is limited by the fact that it is
purely descriptive. The DSM is explicitly a-theoretical and
makes no attempt to offer causal explanations of the con-
ditions it describes.
Despite the difficulties and limitations associated with
DSM and ICD's categories, some WPs emphasized their
usefulness. Philosopher Kenneth Schaffner mentioned
that rheumatoid arthritis is a complex and dimensional
trait, but that clinicians find the categorization of its types
useful. Michael First pointed out that: psychiatrists, like
other physicians operating out of the medical model, have
to make categorical decisions (whether or not to treat);
categories facilitate communication between clinicians;
and categories are a central part of the ongoing psychiatric
enterprise, including basic research, practice, and drug
development. Moreover, First suggested, eliminating the
categories would be an administrative nightmare, would
require massive retraining of all in the mental health field,
and would disrupt research practices. He recommended
moving to a hybrid approach, which would integrate
dimensions with categories and would, for example, indi-
cate the severity of the disorder and the range of treat-
ments appropriate for different severities.
Others emphasized considerable skepticism about the
usefulness of the current categories. Pediatrician William
Carey, sociologist Peter Conrad, anthropologist Sara
Harkness, developmental psychologist Charles Super, and
others worried that the categories are too numerous and
wide, and that they unnecessarily and even harmfully
bring children with normal temperamental differences
within the purview of medicine. Pharmacological epide-
miologist Julie Zito suggested that, perhaps due to the
DSM's descriptive approach, a biologically-based treat-
ment model had emerged in which the presence of symp-
toms alone tends to lead to a diagnosis without sufficient
attention being paid to the severity of the symptoms and
the impairment they cause. She is also concerned that a
validity problem continues to plague psychiatry, despite
its efforts to embrace a scientific model [39].
4. Values play an ineliminable role in the diagnosis of 
childhood psychiatric disorders
It became clear to us during the workshop that values are
ineliminable because, as noted above, human emotions
and behaviors are expressed along a continuum – mood,
attention, and activity are all dimensional or quantitative
traits. As Julie Zito observed, just because we can measure
a behavior, label it as disordered, and treat it, does not
mean that it "is" a disorder. The precise boundary between
normal and abnormal phenotypes must be chosen by us,
based on our observation of symptoms and assessments
of harmful dysfunction; it is up to us to determine when
an individual's suffering rises to the level of warranting
treatment.
For example, as child psychiatrist Peter Jensen pointed
out, it may be that widely distributed traits such as those
associated with ADHD once upon a time conferred an
adaptive advantage. Where once those traits may have
helped an individual, today they can be sources of suffer-
ing or dysfunction. As psychiatrist and neurobiologist
Steve Hyman put it, insofar as what counts as a distur-
bance worth treating always entails judgments about what
is harmful for someone, diagnoses are "influenced by pro-
fessional, social, and cultural values."
Current inter- and intra-national variation in patterns of
diagnosis and treatment [40,41] also reflect value differ-
ences and not, or not simply, differences in occurrence. To
explain varying rates of diagnosis, some WPs emphasized
differences across cultures regarding the expectations of
developing children. Child psychiatrist Benedetto Vitiello
observed that culture may not affect the frequency and
presentation of a certain behavior, but it does certainly
influence the interpretation of the behavior. And child
psychiatrist Jörg Fegert pointed out that the intensity of
the desire of parents "to facilitate or even improve the
development and the chances of their children" may also
vary with culture. Sociologist Ilina Singh added that that
even political agendas within psychiatry (e.g. a concern to
be not like the USA) might affect diagnostic rates. On the
other hand, some WPs emphasized that more children are
diagnosed today due to better mental health care. NAMIChild and Adolescent Psychiatry and Mental Health 2008, 2:5 http://www.capmh.com/content/2/1/5
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representative Carol Caruso suggested that more children
are diagnosed earlier because we are better at recognizing
these disorders earlier.
In response to the discussion of the role of values in mak-
ing psychiatric diagnoses, some WPs emphasized the role
that values play in all diagnoses, whether in psychiatry or
the rest of medicine. Psychiatrist Michael First observed
that there is nothing surprising or unsettling about the fact
that psychiatric diagnoses, like other medical diagnoses,
entail the value judgment that suffering is bad. Some WPs
also emphasized the reasonableness of treating dysfunc-
tion wherever we see it, whether we call it a temperamen-
tal difference or a disorder (or whether we call the person
"bad" or "mad"). Steve Hyman asked, "If someone is suf-
fering, should we care whether its source is a temperamen-
tal difference or a disorder? Shouldn't we relieve that
suffering if we have the tools?"
Others, however, emphasized that value judgments play a
larger role in psychiatry than in other branches of medi-
cine. Former editor of the New England Journal of Medicine,
Marcia Angell said that "The DSM IV ... is the product of
judgments of about 170 experts, but not necessarily sup-
ported by published data. Of necessity, these judgments
are often subjective. [Psychiatric disorders are] not like
cancer or heart failure." This subjectivity – combined with
the observation that traits are dimensional – led some
WPs to advocate letting natural differences be – being
slower to intervene. Pediatrician William Carey, for exam-
ple, argued that children have a huge variety of tempera-
ments (behavioral styles) and adjustments (behavioral
content) and that this variety is normal. But because we
lack an adequate available rating system for the dimen-
sions of normal temperament and adjustment, he warned
that "given a choice between categorical abnormal diag-
nosis and nothing, the clinician may be tempted to over-
use the abnormal." If a child presents with a normal
temperamental or adjustment difference, we should, he
suggested, leave the child be – or we should manage the
child's behavior with counseling (as opposed to psycho-
therapy or drugs).
5. Rather than be for or against medicalization, we need to 
get better at distinguishing between good and bad forms of 
medicalization
As Benedetto Vitiello observed, we can all agree that, to
the extent that medicalizing childbirth saves the lives of
women and children, it is good; similarly, we can agree
that labeling political dissenters as mentally ill (a form of
medicalization that occurred in the former Soviet Union)
is bad. It was religious studies scholar, Sidney Callahan,
who articulated the group's widely shared view that we
need to get clearer about the difference between "good"
and "bad" forms of medicalization.
Again, though, different WPs emphasized different points.
Psychiatrist John Sadler, for example, argued that medi-
cine's primary focus should be to treat non-moral prob-
lems and that other social institutions (education,
religion, criminal justice) should address the moral prob-
lems that too-often have crept into DSM's and psychiatry's
ambit (e.g., Conduct Disorder): As he put it, "The mental
health field should draw stricter boundaries between
mental disorders and vice." Sadler believes that, as we
define more and more moral problems as medical prob-
lems, we confuse the public about what he takes to be the
fundamental difference between "badness" and "mad-
ness," between wrongful or criminal conduct and mental
illness. Philosopher Bonnie Steinbock suggested that,
whatever the conceptual difficulties with the distinction
between "bad" and "mad," it would be pragmatically
impossible to give it up entirely, since a criminal justice
system requires us to be able to distinguish between crim-
inal behavior – which is generally deserving of punish-
ment – and behavior that, because it is the product of
mental disorder, may not be deserving of punishment.
Some WPs, however, emphasized that we should use
medicine if it helps achieve our aims, regardless of
whether those aims are traditionally within the purview of
medicine. Along the lines of psychiatrist Michael First
above, psychiatrist Benedetto Vitiello argued: "Our society
has decided that pain, suffering, murder, aggression are
bad. Getting along with others, respecting the law are
good. And these are the same values that medicine has to
pursue. In some ways it's irrelevant if disorders are classi-
fied as illness or vice."
6. Even when child psychiatrists can agree about the 
boundary between healthy and disordered emotions and 
behaviors in children, misdiagnosis remains a problem
Even those who whole-heartedly accept the DSM or ICD
definitions of a given childhood psychiatric disorder,
agree that there are children who need treatment who are
not getting it and children who do not need treatment
who are. As psychiatrist and neurobiologist Steve Hyman
said, "There are some kids who are sick and are ignored
and there are some annoying kids who are getting medi-
calized and we can't tell them apart very well."
Some WPs emphasized that children who do not need
stimulants are getting them anyway. Epidemiologist Jane
Costello pointed out that, in the Great Smoky Mountains
study, "More children without ADHD than with it
received prescriptions of stimulants." On the other hand,
children who need stimulant treatment are not getting it.
Costello also pointed out that another finding of the GSM
study is that the percentage of children with ADHD who
are not receiving medication is too large (28%) [42]. The
recent epidemiological study of parent reports by Froeh-Child and Adolescent Psychiatry and Mental Health 2008, 2:5 http://www.capmh.com/content/2/1/5
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lich et al. suggests that "less than half of children who met
DSM-IV ADHD criteria had reportedly had their condi-
tions diagnosed by a health care professional or been
treated with medications [43]."
7. Once a line is drawn between healthy and disordered 
emotions and behaviors in children, both pharmacological 
and non-pharmacological treatments can be appropriate
Some WPs emphasized the similar effects achieved by
drugs and psychosocial interventions and argued that it
makes no moral difference which kind of intervention we
use. As Steve Hyman pointed out, "both psychotropic
drugs and lived experience produce long-term changes in
the brain that are not well understood." He acknowledges
that long-term developmental effects of psychotropic
drugs are not known – but pointed out that neither are the
long-term effects of no treatment. Nor do we have a good
understanding of the effects, or efficacy, of psychosocial
interventions. He argued that, in fact, psychosocial inter-
ventions can have negative consequences. Hyman sug-
gested that there is a "cultural bias that behavioral
interventions are totally benign and less potent" and
argued that a preference for non-pharmacological treat-
ment was a symptom of what he called "pharmacological
Calvinism," or an unexamined gut feeling about the
wrongness of using pharmacological means to treat men-
tal disorders.
Making a related point, psychiatric epidemiologist Jane
Costello described a study in which two groups of chil-
dren were compared over time; one group had a complex
psychosocial intervention and the other group had no
intervention: the "intervention was multi-systemic ther-
apy, behavioral treatment, psychotherapy, financial sup-
port, etc. for five years [44]. In adulthood, on every
measure, the intervention group did significantly worse
than the non-intervention group."
Others, however, believe that our choice of means to
intervene matters morally and that psychosocial and envi-
ronmental approaches are sometimes preferable because
of their net effect on the developing child and/or because
they get to the root of the problem rather than merely
altering the child to fit a problematic environment.
Anthropologist Sara Harkness argued that in order to
address suffering we need to consider "treating" the
child's environment rather than only treating the child. As
developmental psychologist Charlie Super observed: If
80% of children have diarrhea, the answer is not only to
give them all medication, but to also treat the problem at
the macro-level. In the case of childhood mental disor-
ders, this could include influencing parenting practices
and the institutions in which children spend time, like
schools. Pediatrician Bill Carey argued that what he calls
temperamental differences (what some others may call
disorders) "can generally be managed satisfactorily by
counseling toward accommodation and improving the
interaction and fit, but not by medication or psychother-
apy."
In terms of patient and family preferences, child psychia-
trist Benedetto Vitiello noted that there is some evidence
that, in general, parents would prefer therapy or other
non-pharmacological treatment over drugs, although
many nonetheless choose drugs because they are consid-
ered significantly cheaper and easier to administer. Educa-
tional psychologist Roy Martin also noted that in schools
"there is enormous pressure for a quick fix; a pill."
8. We need to be attentive to the political, economic, legal, 
institutional realities and health systems in which 
children's emotional and behavioral disturbances occur 
and are treated
Some WPs, like pediatrician Kelly Kelleher, emphasized
the continued negative effect of the traditional separation
of psychiatry from the rest of medicine on health policy
and funding for mental health services. There was also
concern that, in the face of efforts to integrate mental
health care into general medical care and to secure com-
parable funding for mental health services, the anti-psy-
chiatry movement might be able to prevent the provision
of mental health services, including screening of children.
Many WPs also emphasized the need for further research
on the efficacy of treatments and the effects and effective-
ness of treatments on (developing) children; child psychi-
atrist Jon McClellan, for instance, argued that finding
efficacious treatments remains a large challenge. Epidemi-
ologist Julie Zito argued that further research was required
to provide physicians and patients with the information
they need to make informed decisions about the risks and
benefits of different treatment options. Some also empha-
sized the need for better training. They saw a lack of exper-
tise in those who are doing much of the diagnosing and
treating of children and a lack of necessary tools in pedi-
atric primary care. Steve Hyman mentioned the concern
that "many psychotropic drugs are prescribed by primary
care physicians who may not have the tools [to do ade-
quate diagnosis]." Educational psychologist Roy Martin
expressed a similar concern about the involvement of
teachers and schools, observing that "most children are
initially referred for interventions for behavioral and
learning problems based on teacher perceptions," yet
teachers have little training in understanding individual
differences. In the absence of expertise, Martin argued,
they must of necessity base their decisions on inexplicit
norms and, when asked to complete behavior rating
scales, risk being influenced by factors not related to the
student.Child and Adolescent Psychiatry and Mental Health 2008, 2:5 http://www.capmh.com/content/2/1/5
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All agreed that the cost of screening and treatment is
important and must always be borne in mind. Julie Zito
noted that screening for problems with hearing, vision,
and diabetes is non-controversial, as is childhood vaccina-
tion. Yet in the area of mental health, screening for emo-
tional and behavioral disturbances is far more
controversial, partly because of the high false positive rate
[45]. There was specific concern that not enough data exist
on the costs of treating and not treating, including data
that consider the costs to other systems/institutions, such
as the cost to the justice system, of not treating children
with behavioral problems or of choosing one kind of
treatment over another. Addressing both cost and quality
of care concerns, pediatrician Kelly Kelleher suggested that
one reason too few children get the treatment they need is
that the current system (paper instruments are used to
diagnose and track treatments) is inefficient and should
be replaced with computerized risk assessments that dis-
play results with clinical guidance. Such an approach
would provide faster results, lower variable costs, and
more accurate responses from patients [46].
There was also widespread agreement that organizations
with economic or ideological commitments can stand in
the way of children and families getting the best possible
help in dealing with emotional and behavioral distur-
bances. The Citizens Commission on Human Rights, for
example, which is sponsored by the Church of Scientol-
ogy, opposes many practices in psychiatry including the
use of many psychotropic medications. In relation to the
pharmaceutical industry, former NEJM editor Marcia Ang-
ell observed: "The misuse of psychotropic medications in
kids is all too common and I believe if you look behind it
you find the pharmaceutical industry to a great extent."
According to Angell, with the still relatively new practice
of a company giving complex protocols to doctors, which
are intended to make one company's product look better
than another's, "the research establishment is now essen-
tially bought." Some, however, worry less than others.
Psychiatrist Jörg Fegert observed that the studies are so
complicated, regulated, and expensive that they cannot be
conducted without industry support.
Conclusion
As the debates about the treatment of childhood emo-
tional and behavioral disturbances grow more common,
complex, and public, it is reasonable to expect similar
points of agreement and disagreement to emerge. Being
on the lookout for them, and remembering that even
where there are disagreements there are also points of fun-
damental agreement, might make those debates more
productive in the future than they have been in the past.
As the discussion at the first of our 5 workshop series
showed, our understanding of the emergence of complex
human traits is in its infancy [47]. Particular and con-
tested values inform decisions about which behaviors
and/or emotions deserve treatment and which do not. We
should expect the kinds of differing perspectives recorded
at this workshop. Some individuals will argue that society
can reduce the suffering of children by more aggressively
diagnosing and treating them with or without drugs. Oth-
ers will argue that reducing the suffering of children (and
the rest of us) calls for more aggressively expecting and
affirming different ways of being a child – that is, eschew-
ing aggressive diagnosing and treating and paying more
attention to changing cultural practices and environ-
ments. All should agree, however, that what we might call
"therapeutic humility" – being clear about the limits of
understanding – is called for, as is more research on both
the causes of behavioral and emotional disturbances and
the most effective and respectful ways of responding to
them.
Authors' contributions
The authors contributed equally to this work and both
read and approved the final manuscript.
Acknowledgements
We are deeply grateful to Alison Jost for her research assistance.
Workshop participants (institutional affiliations are in USA unless other-
wise noted) were the authors, Erik Parens and Josephine Johnston, and:
Marcia Angell, Senior Lecturer in Social Medicine, Department of Social 
Medicine, Harvard Medical School;
Sidney Callahan, Distinguished Scholar, The Hastings Center;
William B. Carey, Clinical Professor of Pediatrics, University of Pennsyl-
vania School of Medicine, Division of General Pediatrics, The Children's 
Hospital of Philadelphia;
Carol Caruso, Board of Directors, National Alliance on Mental Illness;
Peter Conrad, Harry Coplan Professor of Social Sciences, Department of 
Sociology, Brandeis University;
Elizabeth Jane Costello, Professor of Psychology, Duke University Med-
ical Center;
Jörg Fegert, Professor and Chair of Child and Adolescent Psychiatry and 
Psychotherapy, University of Ulm, Medical Director of the Department of 
Child and Adolescent Psychiatry and Psychotherapy, Ulm University Hos-
pital, Germany;
Michael B. First, New York Psychiatric Institute, Department of Psychia-
try, Columbia University;
Sara Harkness, Professor of Human Development, Pediatrics & Anthro-
pology, Director, Center for the Study of Culture, Health, and Human 
Development, University of Connecticut;
Steven E. Hyman, Provost, Harvard University, Professor of Neurobiol-
ogy, Harvard Medical School;Child and Adolescent Psychiatry and Mental Health 2008, 2:5 http://www.capmh.com/content/2/1/5
Page 8 of 9
(page number not for citation purposes)
Peter S. Jensen, Professor of Clinical Psychiatry, Columbia University, 
Research Psychiatrist, New York State Psychiatric Institute;
Kelly J. Kelleher, Professor of Pediatrics, Public Health, and Psychiatry, 
Colleges of Medicine and Public Health, and Department of Psychiatry, The 
Ohio State University, Vice President for Health Services Research, Direc-
tor, Center for Innovation in Pediatric Practice, Columbus Children's 
Research Institute;
Julia Kim-Cohen, Assistant Professor, Department of Psychology, Yale 
University;
Roy P. Martin, Professor Emeritus, Department of Educational Psychol-
ogy, University of Georgia;
Jon McClellan, Associate Professor, Department of Psychiatry, University 
of Washington;
John Z. Sadler, Daniel W. Foster Professor of Medical Ethics, Professor 
of Psychiatry & Clinical Sciences, Director, UT Southwestern Program in 
Ethics in Science and Medicine, Director, Center for Values in Medicine, 
Science, & Technology The University of Texas at Dallas, Co-Editor: Philos-
ophy, Psychiatry, & Psychology, Department of Psychiatry, University of Texas 
Southwestern;
Kenneth F. Schaffner, University Professor of History and Philosophy of 
Science, Professor of Psychiatry, University of Pittsburgh;
Ilina Singh, Wellcome Trust University Lecturer in Bioethics and Society, 
London School of Economics and Political Science, United Kingdom;
Bonnie Steinbock, Professor, Department of Philosphy, University at 
Albany/SUNY;
Charles M. Super, Professor of Human Development and Family Studies, 
Co-Director, Center for the Study of Culture, Health, and Human Devel-
opment, University of Connecticut;
Benedetto Vitiello, Chief, Child & Adolescent Treatment & Preventive 
Intervention Research Branch, National Institute of Mental Health;
Julie Magno Zito, Associate Professor of Pharmacy and Psychiatry, Uni-
versity of Maryland.
Funded by grant U13 MH78722 of the National Institute of Mental Health 
to the Hastings Center (Principal Investigator: Erik F. Parens, Ph.D.)
References
1. Rutter M, Smith D: Psychosocial Disorders in Young People: Time Trends
and their Causes Chichester UK: Wiley; 1995. 
2. US Department of Health and Human Services: Mental Health: A
Report of the Surgeon General Rockville MD: U.S. Department of
Health and Human Services; 1999. 
3. Kessler RC, Berglund P, Demler O, Robert J, Merikangas KR, Walters
EE:  Lifetime prevalence and age-of-onset distributions of
DSM-IV disorders in the National Comorbidity Survey Repli-
cation.  Arch Gen Psychiatry 2005, 62:593-602.
4. Egger HL, Angold A: Common emotional and behavioral disor-
ders in preschool children: presentation, nosology, and epi-
demiology.  J Child Psychol Psychiatry 2006, 47:313-37.
5. Safer DJ, Zito JM, Fine EM: Increased methylphenidate usage for
attention deficit disorder in the 1990s.  Pediatrics 1996, 98(6 Pt
1):1084-88.
6. Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F: Trends
in the prescribing of psychotropic medications to preschool-
ers.  JAMA 2000, 283:1025-30.
7. Delate T, Gelenberg AJ, Simmons VA, Motheral BR: Trends in the
use of antidepressants in a national sample of commercially
insured pediatric patients, 1998 to 2002.  Psychiatric Services
2004, 55:387-91.
8. Habel LA, Schaefer CA, Levine P, Bhat AK, Elliott G: Treatment
with stimulants among youths in a large California health
plan.  J Child Adolesc Psychopharmacol 2005, 15:62-67.
9. Medco Health Solutions   [http://phx.corporate-ir.net/phoe
nix.zhtml?c=131268&p=irol-newsArticle&ID=571791&highlight=]
10. Olfson M, Marcus SC, Weissman MM, Jensen PS: National trends
in the use of psychotropic medications by children.  J Am Acad
Child Adolesc Psychiatry 2002, 41:514-21.
11. Zito JM, Safer DJ, dosReis S, Gardner JF, Magder L, Soeken K, Boles
M, Lynch F, Riddle MA: Psychotropic practice patterns for
youth: a 10-year perspective.  Arch Pediatr Adolesc Med 2003,
157:17-25.
12. Timimi S, Taylor E: ADHD is best understood as a cultural con-
text: for and against.  British Journal of Psychiatry 2004, 184:8-9.
13. Coghill D: Use of Stimulants for Attention Deficit Hyperactiv-
ity Disorder.  BMJ 2004, 329:907-08.
14. Biederman J: Attention-deficit/hyperactivity disorder: a selec-
tive overview.  Biological Psychiatry 2005, 57:1215-20.
15. Singh I: Doing their jobs: mothering with Ritalin in a culture of
mother-blame.  Social Science and Medicine 2004, 59(6):1193-1205.
16. Conrad P, Potter D: From Hyperactive Children to ADHD
Adults: Observations on the Expansion of Medical Catego-
ries.  Social Problems 2000, 47:559-82.
17. Olfman S, (Ed): No Child Left Different Westport, CT Praeger Publish-
ers; 2006. 
18. Jensen P, Knapp P, Mrazek D: Toward a New Diagnostic System for Child
Psychopathology: Moving Beyond DSM NY & London: The Guilford
Press; 2006. 
19. Nardi BA, Whittaker S: The Place of Face-to-Face Communica-
tion in Distributed Work.  In Distributed Work Edited by: Hinds P,
Kiesler S. Cambridge: The MIT Press; 2002:83-110. 
20. Boix-Mansilla V, Gardner H: Assessing interdisciplinary work at
the frontier: An empirical exploration of "symptoms of qual-
ity.  2004 [http://www.goodwork.org]. GoodWork Project Website
Research Paper
21. Klein JT: Interdisciplinarity: History, Theory, and Practice Detroit: Wayne
State University Press; 1990. 
22. Moran J: Interdisciplinarity London: Routledge; 2002. 
23. Nowotny H, Scott P, Gibbons M: Re-thinking Science. Knowledge and
the Public in an Age of Uncertainty Cambridge: Polity Press; 2001. 
24. Turner B: The interdisciplinary curriculum: from social medi-
cine to postmodernism.  Sociology of Health and Illness 1990,
12:1-23.
25. National Institutes of Health. Interdisciplinary Research
[http://nihroadmap.nih.gov/interdisciplinary/index.asp]
26. Epstein SL: Making interdisciplinary collaboration work.  I n
Interdisciplinary collaboration: an emerging cognitive science Edited by:
Derry SJ, Gernsbacker MA. Mahwah, NY: Erlbaum; 2005:245-263. 
27. Schunn C, Crowley K, Okada T: What Makes Collaborations
Across a Distance Succeed? The Case of the Cognitive Sci-
ence Community.  In Distributed Work Edited by: Hinds P, Kiesler
S. Cambridge: The MIT Press; 2002:407-432. 
28. Harkness S, Moscardino U, Rios Bermudez M, Zylicz PO, Welles-
Nystrom B, Blom M, Parmar P, Axia G, Super CM: Mixed methods
in international collaborative research: The experiences of
the International Study of Parents, Children, and Schools.
Cross-Cultural Research 2006, 40:65-82.
29. Harkness S, Super CM, Moscardino U, Rha JH, Blom M, Huitrón B,
Johnston C, Sutherland M, Hyun OK, Axia G, Palacios J: Cultural
models and developmental agendas: Implications for arousal
and self-regulation in early infancy.  Journal of Developmental Proc-
esses 2007, 2:5-39.
30. Super C, Harkness S, Axia G, Welles-Nyström B, Palacios J, Zylicz
PO, McGurk H: Culture, temperament, and the 'difficult
child.'.  European Journal of Developmental Science  in press.
31. Sapolsky RM: Glucocorticoids and Hippocamapl Atrohpy in
Neuropsychiatric disorders.  Arch Gen Psychiatry 2000, 57:925-35.
32. Duman RS: Structural alterations in depression: cellular
mechanisms underlying pathology and treatment of mood
disorders.  CNS Spectrums 2002, 7:140-47.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Child and Adolescent Psychiatry and Mental Health 2008, 2:5 http://www.capmh.com/content/2/1/5
Page 9 of 9
(page number not for citation purposes)
33. Sullivan PF, Neale MC, Kendler KS: Genetic epidemiology of
major depression: review and meta-analysis.  American Journal
of Psychiatry 2000, 157:1552-62.
34. Eisenberg L: Experience, Brain, and Behavior: The Importance
of a Head Start.  Pediatrics 1999, 103:1031-35.
35. Burke HM, Davis MC, Otte C, Mohr DC: Depression and cortisol
responses to stress: a meta-analysis.  Psychoneuroendocrinology
2005, 30:846-56.
36. Kim-Cohen J, Caspi A, Taylor A, Williams B, Newcombe R, Craig I,
Moffitt TE: MAOA, maltreatment, and gene-environment
interaction predicting children's mental health: New evi-
dence and a meta-analysis.  Molecular Psychiatry 2006, 11:903-13.
37. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et
al.: Influence of life stress on depression: Moderation by a pol-
ymorphism in the 5-HTT gene.  Science 2003, 301:386-89.
38. Moffitt TE, Caspi A, Rutter M: Strategy for investigating interac-
tions between measured genes and measured environ-
ments.  Arch Gen Psychiatry 2005, 62:473-81.
39. Eriksen K, Kress VE: Beyond the DSM Story Thousand Oaks CA: Sage
Publications; 2005. 
40. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA: The
worldwide prevalence of ADHD: a systematic review and
metaregression analysis.  American Journal of Psychiatry 2007,
164:942-48.
41. LeFever GB, Dawson KV, Morrow AL: The extent of drug ther-
apy for attention-deficit/hyperactivity disorder among chil-
dren in public schools.  American Journal of Public Health 1999,
89:1359-64.
42. Angold A, Erkanli A, Egger HL, Costello EJ: Stimulant treatment
for children: a community perspective.  J Am Acad Child Adolesc
Psychiatry 2000, 39:975-84.
43. Froehlich ET, Lanphear BP, Epstein JN, Barbaresis WJ, Katusic SK,
Kahn RS: Prevalence, recognition, and treatment of Atten-
tion-Deficit/Hyperactivity Disorder in a national sample of
US children.  Arch Pediatr Adolesc Med 2007, 161:857-64.
44. McCord J: A thirty-year follow-up of treatment effects.  Am Psy-
chol 1978, 33:284-89.
45. Shaffer D, Scott M, Wilcox H, Maslow C, Hicks R, Lucas CP, Garfinkel
R, Greenwald S: The Columbia Suicide Screen: validity and
reliability of a screen for youth suicide and depression.  J Am
Acad Child Adolesc Psych 2004, 43(1):71-79.
46. National Initiative for Improving Children's Healthcare
Quality, Improving Care for Children with ADHD   [http://
www.nichq.org/NR/rdonlyres/67EFB37E-37DC-4868-A4DB-
28BC2C82B532/3816/ADHDDissemBook.pdf]
47. Hyman SM: Can neuroscience be integrated into the DSM?
Nature Reviews Neuroscience 2007, 8:725-32.